Watchlist Price Alert

MIRA Pharmaceuticals Inc. (MIRA)

NASDAQ: MIRA · Real-Time Price · USD

1.42

0.05 (3.65%)

At close: Jun 06, 2025, 3:57 PM

1.40

-1.41%

After-hours: Jun 06, 2025, 04:00 PM EDT

MIRA Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q1 2022	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.21M	2.83M	4.14M	2.82M	3.53M	4.6M	5.87M	24.82K	1.35K	350.98K	n/a	2.12M	-3.49K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.98K
Long-Term Investments	n/a	n/a	n/a	n/a	93.49K	69.15K	50K	50K	n/a	n/a	n/a	135K	n/a
Other Long-Term Assets	35.44K	35.44K	35.44K	83.17K	n/a	n/a	2.78M	3.22M	n/a	-0.00	n/a	723.85K	-3.49K
Receivables	n/a	n/a	n/a	n/a	n/a	11.86K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	158.61K	n/a	n/a	n/a	n/a	11.86K	n/a	353.37K	189.69K	143.43K	n/a	n/a	n/a
Total Current Assets	1.36M	2.89M	4.23M	2.93M	3.71M	4.86M	6.07M	420.72K	251.07K	494.4K	n/a	2.12M	3.49K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	1.27K	5.06K	114.36K	132.33K	146.51K	363.67K	n/a	194.19K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	35.44K	35.44K	35.44K	83.17K	94.76K	74.21K	2.95M	3.4M	146.51K	363.67K	n/a	1.05M	-3.49K
Total Assets	1.4M	2.92M	4.27M	3.02M	3.81M	4.93M	9.02M	3.83M	397.58K	858.07K	n/a	3.18M	n/a
Account Payables	100.67K	723.35K	692.83K	782.14K	636.26K	538.56K	510.69K	645.14K	918.62K	905.55K	n/a	210.14K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-210.14K	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	5.06K	n/a	1.8M	219.54K	133.06K	n/a	243.06K	n/a
Other Current Liabilities	5.5K	n/a	n/a	n/a	n/a	-5.06K	268.88K	n/a	685.46K	n/a	n/a	0.00	n/a
Total Current Liabilities	106.17K	723.35K	692.83K	796.61K	652.01K	558.1K	868.37K	2.58M	2.12M	1.37M	n/a	534.26K	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	34.53K	51.47K	68.21K	84.27K	n/a	136.23K	n/a
Total Liabilities	106.17K	723.35K	692.83K	796.61K	652.01K	558.1K	902.9K	2.63M	2.19M	1.45M	n/a	670.49K	n/a
Total Debt	n/a	n/a	n/a	n/a	1.27K	5.06K	108.86K	1.93M	360.55K	491.23K	n/a	431.76K	n/a
Common Stock	1.68K	1.66K	1.63K	1.48K	1.48K	1.48K	1.48K	6.66K	6.66K	6.66K	n/a	6.54K	n/a
Retained Earnings	-30.92M	-29.14M	-26.74M	-24.69M	-23M	-21.29M	-15.5M	-11.91M	-10.64M	-9.3M	n/a	-3.72M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	-135K	-67.99K
Shareholders Equity	1.29M	2.2M	3.57M	2.22M	3.16M	4.37M	8.12M	1.2M	-1.79M	-596.23K	n/a	2.51M	-67.99K
Total Investments	n/a	n/a	n/a	83.17K	93.49K	69.15K	50K	50K	n/a	n/a	n/a	135K	6.98K